Literature DB >> 6405912

Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.

I E Smith, A L Harris, R Stuart-Harris, H T Ford, J C Gazet, H White, C L Harmer, L Carr, J A McKinna, M Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6405912      PMCID： PMC1547913          DOI： 10.1136/bmj.286.6378.1615

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

Review 1.  Tamoxifen in advanced breast cancer.

Authors:  H Mouridsen; T Palshof; J Patterson; L Battersby
Journal:  Cancer Treat Rev       Date:  1978-09       Impact factor: 12.111

2.  Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.

Authors:  H T Mouridsen; T Palshof; C Rose
Journal:  Recent Results Cancer Res       Date:  1980

3.  Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Authors:  I E Smith; A L Harris; M Morgan; H T Ford; J C Gazet; C L Harmer; H White; C A Parsons; A Villardo; G Walsh; J A McKinna
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28
  3 in total
  3 in total

1.  Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.

Authors:  I E Smith; V Macaulay
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.

Authors:  M Dowsett; A L Harris; I E Smith; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

3.  Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

Authors:  R Stuart-Harris; D W Hedley; I W Taylor; A L Levene; I E Smith
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.